http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0710750-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7f75780245ab029ad042060276ad22a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-004
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
filingDate 1994-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9906d2892c6a512ec02d4441fa909407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a19a74153dc5381b00fc317f79853a9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fa3e35d3eaa789dfda9c57cf31f520a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6f5bb23e26f87721eb3b07d75cd83c6
publicationDate 1995-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0710750-A
titleOfInvention Cosmetic or dermatological formulations containing δ-aminorivulinic acid
abstract (57) [Summary] [Structure] A cosmetic or dermatological formulation containing δ-aminorivulinic acid as an active material. This formulation can mitigate the adverse effects caused by exposure to light, especially UV light, and also acts as a protectant if applied before exposure to light, especially UV light.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009123116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7425042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003526637-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9333156-B2
priorityDate 1993-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985

Total number of triples: 39.